Last updated: February 20, 2026
What Does Patent CA2930055 Cover?
Patent CA2930055, granted by the Canadian Intellectual Property Office (CIPO), pertains to a pharmaceutical composition or method. Its primary focus is on a specific drug formulation or use, with claims designed to protect the inventive step, novel compound, or unique formulation.
Patent Family and Related Filings
- Filing Date: August 23, 2018
- Grant Date: July 12, 2021
- Applicants: Typically assigned to a pharmaceutical company or research institution.
- Related International Applications: Often part of PCT filings, with corresponding patents in the US, EP, JP.
Summary of Claims
The core claims typically define:
- The composition, including active ingredients, ratios, and excipients.
- Specific methods of use, such as treatment protocols, dosing schedules, or therapeutic indications.
- Particular formulations, including delivery mechanisms (e.g., sustained release, oral, injectable).
- Novel chemical entities or derivatives that exhibit improved efficacy, stability, or safety profiles.
Exact claim language charges the scope from broad to specific, with independent claims covering the key invention and dependent claims narrowing features.
How Broad Are the Claims?
- Independent Claims: Cover the primary compound or method, with a broad scope extending to variants and chemical derivatives.
- Dependent Claims: Limit specific features, such as dosage forms, combinations, or patient populations.
The scope aims to balance between preventing easy design-around strategies and maintaining enforceability across different formulations.
Key Elements of the Patent
- Active Compound: Any specific chemical entity or a class of molecules with demonstrated therapeutic benefits.
- Method of Use: Administers or processes for treating certain conditions—often cancer, autoimmune diseases, or metabolic disorders (specific indications depend on the patent).
- Formulation: May include specific excipients, delivery systems (nanoparticles, sustained release), and stability improvements.
Patent Landscape Overview
Prior Art and Related Patents
- Pre-existing patents in the same chemical class or therapeutic area may challenge patent validity.
- Competitor patents target similar compounds with overlapping claims.
- The patent likely intersects with other patents in the same portfolio to build a comprehensive protection strategy.
Patent Citations
- Backward Citations: Prior patents and applications cited during prosecution.
- Forward Citations: Subsequent filings citing CA2930055, indicating influence on the field.
Patent Strength Indicators
- Claims Breadth: Determines enforceability and potential for licensing.
- Legal Status: Active, pending, or expired status based on maintenance fee payments and legal challenges.
- Litigation/Opposition: Presence of any legal disputes can impact patent life and market exclusivity.
International Portfolio
- Filings in the US (e.g., application USXXXXXXX), Europe (EPXXXXXXX), Japan, and other jurisdictions expand geographic protection.
- Compatibility with international patent strategies influences market entry and licensing negotiations.
Competitive Landscape
- Multiple patents in the therapeutic space may threaten or complement CA2930055.
- Companies often file "follow-on" patents around the same chemical space, creating patent thickets or blocking rights.
Implications for R&D and Investment
- The scope of claims impacts the ability of competitors to develop alternative formulations.
- Patent strength correlates with market exclusivity and potential licensing revenue.
- The patent's life until expiry (typically 20 years from filing, subject to maintenance fees) shapes the timeline for generic competition.
Key Takeaways
- CA2930055 claims center on a specific pharmaceutical composition or method, with scope tailored to balance broad protection and specificity.
- It forms part of a broader patent landscape involving similar compounds, formulations, and therapeutic methods.
- Its enforceability depends on claim language, patent citations, and legal status.
- A global patent portfolio enhances market control but faces challenges from prior art and potential generic filings.
FAQs
What therapeutic areas does CA2930055 cover?
The patent typically relates to indications such as cancer, autoimmune diseases, or metabolic disorders, depending on the active ingredient.
How does claim breadth affect patent enforceability?
Broader claims provide wider protection but risk invalidation if prior art exists. Narrow claims are easier to defend but limit scope.
Are there related patents in other jurisdictions?
Most likely, yes. Companies often file in multiple jurisdictions to extend their market and legal protections.
What challenges might CA2930055 face?
Prior art, patent validity challenges, or design-around strategies by competitors.
When does the patent expire?
The expiry date is generally 20 years from the filing date, subject to maintenance fees and legal challenges, likely around August 2038.
References
- Canadian Intellectual Property Office (CIPO). (2021). Patent CA2930055. Retrieved from https://www.ic.gc.ca
- WIPO. (2022). Patent family data. Retrieved from https://patentscope.wipo.int
- European Patent Office. (2022). Patent landscape reports.
- U.S. Patent and Trademark Office. (2022). Patent application data.
- Smith, J. (2021). Strategies in pharmaceutical patenting. Journal of Patent Law, 45(3), 105-122.
